{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-263536","form_type":"8-K","ticker":"BEAM","cik":"0001745999","company_name":"Beam Therapeutics Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.326030+00:00","generated_at":"2026-05-17T00:39:59.903735+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Beam Q3 net loss $112.7M; cash $1.1B; BEAM-302 expands; Orbital acquisition by BMS","bullets":["Net loss of $112.7M ($1.10 per share) in Q3 2025 vs $96.7M ($1.17 per share) in Q3 2024.","Cash, cash equivalents and marketable securities $1.1B as of Sep 30, 2025, up from $850.7M at Dec 31, 2024; runway into 2028.","BEAM-302 expanded: multi-dose cohort (60 mg x2, 8 wks apart) in Part A; first patient dosed in Part B (liver disease). Data in early 2026.","BEAM-101 updated data accepted for ASH Dec 2025; FDA granted RMAT designation in Aug 2025.","First subject dosed with BEAM-103 (ESCAPE mAb) in Phase 1 HV trial; BMS to acquire Orbital for $1.5B; Beam holds ~17% stake."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-263536","json":"https://secwatch.observer/filing/0001193125-25-263536.json","markdown":"https://secwatch.observer/filing/0001193125-25-263536.md","text":"https://secwatch.observer/filing/0001193125-25-263536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525263536/0001193125-25-263536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745999/000119312525263536/beam-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:39:59.903735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}